McMaster University

Why we need to reuse waste energy to achieve net-zero heating systems

Retrieved on: 
Monday, July 31, 2023

As we move toward a cleaner energy future, there is a growing push to electrify everything, from cars to home heating.

Key Points: 
  • As we move toward a cleaner energy future, there is a growing push to electrify everything, from cars to home heating.
  • While that sounds ideal, it is also much more than a matter of simply plugging in.

The importance of heating

    • To compare the overall energy required for heating and cooling buildings we look at heating degree days (HDD) versus cooling degree days (CDD).
    • In Toronto, for example, heating degree days outnumber cooling degree days about 7-1.

Utilize everything

    • By storing the heat generated from all sources, including waste heat, and drawing from it through the coldest months of the year, our research shows we can use discarded waste heat.
    • A huge amount of heat generated today is simply dissipated into our surroundings and wasted, and when it’s cold outside, we use new energy to make fresh heat.
    • There is already technology that can harvest and store such heat for months in underground thermal batteries until it is needed.

Integrated heat harvesting systems

    • McMaster leads a wider research co-operative demonstration project called Integrated Community Energy and Harvesting, or ICE-Harvest, with 30 municipalities and 19 industrial partners taking part.
    • In a new paper in the journal Applied Energy, we show how such localized systems use the same energy twice.

Heat batteries already exist

    • Think of it this way: the Canadian chain Pizza Pizza is piloting a system that uses heat recovered from its ovens to heat its own hot water.
    • In the same way an arena can sell its heat to a retirement home across the street; a grocery store to a neighbouring school, and so on.
    • Here in the northern hemisphere, heat is a valuable resource that’s already there waiting to be tapped, and we can no longer afford to waste it.

Fuzionaire Diagnostics, Inc. Announces Name Change to Fuzionaire Theranostics, Inc. and Preclinical Oncology Pipeline

Retrieved on: 
Monday, July 31, 2023

Fuzionaire Diagnostics, Inc. announced today that it has changed its name to Fuzionaire Theranostics, Inc. (“Fuzionaire Tx”).

Key Points: 
  • Fuzionaire Diagnostics, Inc. announced today that it has changed its name to Fuzionaire Theranostics, Inc. (“Fuzionaire Tx”).
  • The HetSiFA® platform creates chemically identical diagnostic and therapeutic companions, a feature that enables a personalized therapeutic dose for each cancer patient.
  • The name change marks a milestone in the company's growth plan and reflects a developing theranostic pipeline in oncology.
  • The modularity of the HetSiFA platform enables the company to expand its pipeline rapidly with existing collaborators and new partners.

Virtualware (EPA:MLVIR) Announces record-breaking First-Half 2023 Results: VR SaaS Business Line Records Steady 208% Growth

Retrieved on: 
Tuesday, July 18, 2023

BILBAO, Spain, July 18, 2023 (GLOBE NEWSWIRE) -- Virtualware (EPA:MLVIR), a pioneering VR company employing a SaaS business model, today announced record-breaking H1 2023 financial results, just three months after it went public in Euronext Access Paris.

Key Points: 
  • BILBAO, Spain, July 18, 2023 (GLOBE NEWSWIRE) -- Virtualware (EPA:MLVIR), a pioneering VR company employing a SaaS business model, today announced record-breaking H1 2023 financial results, just three months after it went public in Euronext Access Paris.
  • In H1 2023, Virtualware reported total revenues of €2.149 million, indicating a 44.71% growth over the previous year.
  • Most of this growth was fueled by subscription plan revenues accounting for €630,000, which show a substantial year-on-year increase of 208.23%.
  • Headquartered in Bilbao, Spain, Virtualware is a global pioneer in developing virtual reality solutions for major industrial, educational, and healthcare conglomerates.

Government of Canada supporting Ontario universities with funding to reduce pollution to achieve environmental success

Retrieved on: 
Thursday, July 13, 2023

This funding will enable eligible facilities to achieve greater energy efficiency, adopt sustainable solutions, and reduce their emissions to support the transition to a low-carbon world.

Key Points: 
  • This funding will enable eligible facilities to achieve greater energy efficiency, adopt sustainable solutions, and reduce their emissions to support the transition to a low-carbon world.
  • McMaster University will receive $2,087,600 to reduce its natural gas usage for campus heating through the installation of electric boilers.
  • By investing pollution pricing proceeds in these forward-thinking institutions, the Government of Canada is supporting their efforts to transition to lower-cost, renewable energy sources.
  • The Government of Canada has committed to return proceeds collected from the OBPS to the jurisdictions of origin.

Ketone drinks: do they really improve sports performance?

Retrieved on: 
Thursday, July 6, 2023

But do they really improve performance?

Key Points: 
  • But do they really improve performance?
  • Ketone bodies can also be used in other tissues, such as muscle, and could eventually be used as fuel during exercise.
  • Initially, most ketone supplements caused gastrointestinal issues and did not sufficiently increase ketone body availability.
  • A newer ketone monoester (ketone body bound to a compound called monoester) drink was shown not to cause gastrointestinal discomfort and to sufficiently increase ketone body concentrations in the blood.

Government strengthens Canada's leadership role in medical isotope production

Retrieved on: 
Tuesday, June 27, 2023

Canada has played a key leadership role in the development and use of medical isotopes for over 70 years, positioning the country as a global leader in the production and supply of medical isotopes.

Key Points: 
  • Canada has played a key leadership role in the development and use of medical isotopes for over 70 years, positioning the country as a global leader in the production and supply of medical isotopes.
  • This funding responds to the Canadian Nuclear Isotope Council's report, Isotopes for Hope: Canadian Leadership Needed Now More Than Ever, calling on the federal government to invest in the growth of Canada's medical isotope ecosystem.
  • The Canadian Medical Isotope Ecosystem will play a crucial role in the development and distribution of medical isotopes and radiopharmaceuticals across the country.
  • The new Canadian Medical Isotope Ecosystem brings together government, industry and academia to work collaboratively to build Canadian medical isotope capabilities and ensure Canada remains a leader in this high-growth sector."

C4 Therapeutics Appoints Leonard Reyno, M.D., as Chief Medical Officer

Retrieved on: 
Tuesday, June 20, 2023

WATERTOWN, Mass., June 20, 2023 (GLOBE NEWSWIRE) -- C4 Therapeutics, Inc. (C4T) (Nasdaq: CCCC), a clinical-stage biopharmaceutical company dedicated to advancing targeted protein degradation science to develop a new generation of small-molecule medicines and transform how disease is treated, today announced the appointment of Leonard (Len) Reyno, M.D., as chief medical officer, effective July 10, 2023. Dr. Reyno is a seasoned biotech executive with nearly 30 years of clinical development experience, spanning first-in-human studies to Phase IV clinical trials. At C4T, Dr. Reyno will be responsible for driving C4T’s clinical strategy to advance its promising pipeline of degrader therapies.

Key Points: 
  • Dr. Reyno is a seasoned biotech executive with nearly 30 years of clinical development experience, spanning first-in-human studies to Phase IV clinical trials.
  • At C4T, Dr. Reyno will be responsible for driving C4T’s clinical strategy to advance its promising pipeline of degrader therapies.
  • “We look forward to leveraging Len’s track record of advancing novel oncology therapeutics to patients, deep strategic and operational experience in clinical development and organizational leadership capabilities,” said Andrew Hirsch, president and chief executive officer of C4 Therapeutics.
  • Prior to Pionyr, he was executive vice president and chief medical officer at ORIC Pharmaceuticals, leading their first product candidate into human trials.

Oasis Names Thomas Atkinson to Advisory Council

Retrieved on: 
Monday, June 12, 2023

Oasis Management Company Ltd. (“Oasis”) is pleased to announce that Thomas Atkinson has joined its Advisory Council.

Key Points: 
  • Oasis Management Company Ltd. (“Oasis”) is pleased to announce that Thomas Atkinson has joined its Advisory Council.
  • From 1996 to 2001 he held progressively senior positions with the Toronto Stock Exchange, including Vice President of Regulation Services.
  • Mr. Atkinson is a frequent speaker and lecturer on topics related to securities regulation, compliance, ethics, management, leadership, and other related topics.
  • “Tom is an experienced leader in global capital markets and international securities market regulation,” said Seth Fischer, Founder and Chief Investment Officer at Oasis.

More than 3,500 Riders Cycle Over 200km to Raise Critical Funds for Cancer Research at The Princess Margaret

Retrieved on: 
Saturday, June 10, 2023

The Princess Margaret unites Riders from across Canada and around the world for the 200km+ Ride to Conquer Cancer on June 10 and 11.

Key Points: 
  • The Princess Margaret unites Riders from across Canada and around the world for the 200km+ Ride to Conquer Cancer on June 10 and 11.
  • TORONTO, June 10, 2023 /CNW/ - More than 3,500 Riders left Exhibition Place in Toronto for The Princess Margaret Cancer Foundation's 16th annual Ride to Conquer Cancer, Canada's largest athletic fundraiser.
  • So far, this year's event has raised $17.3 million for life-saving cancer research and care at Princess Margaret Cancer Centre, one of the top 5 cancer research centres in the world.
  • "Cancer is the leading cause of death in Canada – two in five Canadians will be diagnosed with cancer in their lifetime.

Hammond Power Solutions Announces Adrian Thomas as Chief Executive Officer

Retrieved on: 
Tuesday, June 6, 2023

GUELPH, Ontario, June 06, 2023 (GLOBE NEWSWIRE) -- Hammond Power Solutions Inc. (“HPS” or the “Company”) (TSX: HPS.A) today announced the appointment of Adrian Thomas as the Company's next Chief Executive Officer, replacing Bill Hammond who will assume the position of Executive Chairman after 22 years as the CEO.

Key Points: 
  • GUELPH, Ontario, June 06, 2023 (GLOBE NEWSWIRE) -- Hammond Power Solutions Inc. (“HPS” or the “Company”) (TSX: HPS.A) today announced the appointment of Adrian Thomas as the Company's next Chief Executive Officer, replacing Bill Hammond who will assume the position of Executive Chairman after 22 years as the CEO.
  • Mr. Thomas will also be appointed to HPS’ Board of Directors.
  • "Adrian is a highly capable and seasoned leader with over two decades of experience across the electrical industry and has successfully led teams launching technologies globally,” said Grant Robinson, Lead Director of HPS.
  • Adrian holds a degree in electrical engineering from McMaster University and a post-graduate certificate in finance for executives from Northwestern University's Kellogg School of Management.